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Abstract
Purpose: With intensity modulated radiation therapy (IMRT), the physician can prescribe, design and deliver optimized treat-
ment plans that target the tumor and spare adjacent critical structures. The increased conformity of such plans often comes at the
expenses of adding significant complexity to the delivery of the treatment. With volumetrically modulated arc therapy (VMAT),
in addition to the modulation of the intensity of the radiation beam, other mechanical parameters such as gantry speed and dose
rate are varied during treatment delivery. It is therefore imperative that we develop comprehensive and accurate methods to
validate such complex delivery techniques prior to the commencement of the patient’s treatment. Methods: In this study, a
Monte Carlo simulation was performed for the high definition multileaf collimator (HD-MLC) of a Varian Novalis TX linac. Our
simulation is based on the MCSIM code and provides a comprehensive model of the linac head. After validating the model in
reference geometries, treatment plans for different anatomical sites were simulated and compared against the treatment planning
system (TPS) dose calculations. All simulations were performed in a cylindrical water phantom as opposed to the patient anat-
omy, to remove any complexities associated with density effects. Finally, a comparison through gamma analysis of dose plane
between the simulation, the TPS and the measurements from the Matrixx array (IBA) was conducted to verify the accuracy of our
model against both the measurements and the TPS. Results: Gamma analysis of ten IMRT and ten VMAT cases for different
anatomical sites was performed, using a 3%/3 mm passing criterion. The average passing rates were 97.5% and 94.3% for the
IMRT and the VMAT plans respectively when comparing the MCSIM and TPS dose calculations. Conclusion: In the present work
a Monte Carlo model of a Novalis TX linac which has been tested and benchmarked to produce phase-space files for the treatment
head of the linac was used to produce a input phase-space to calculated dose deposition phenomena in different geometries for
IMRT and VMAT treatment modalities. The control points defined for the MLC were replaced by blocks with the same charac-
teristics and materials of the linac MLC to speed up the simulation time. With this technique a simulation of a typical IMRT case
can be performed with a 10 computer cluster in about 1.02 hours in average. If the number of computer used is increased the
computing time can be reduced even more which make our model suitable for clinical use as a second check method to compare
the TPS dose calculated. Our results showed that for IMRT and VMAT deliveries with a HD-MLC, there is an average of 95.9% of
the points have a gamma index less than 1 with our chosen criterion between our Monte Carlo simulations and the corresponding
measurements and TPS calculations in a cylindrical water equivalent phantom. This Monte Carlo code can be used as
pre-treatment, independent dose calculation verification for IMRT and VMAT deliveries.
Keywords:Monte Carlo simulations; BEAMnrc; MCSIM; Novalis TX; HD-MLC
Introduction
Monte Carlo based radiation transport techniques have been
used for several years as the most accurate method for dose
calculation in radiotherapy 1, including plans for intensity
modulated radiation therapy (IMRT) 2-23. With the introduc-
tion of IMRT, the treatment planning team can generate very
conformal plans with high complexity that can be delivered
either as multi-gantry step-and-shoot or sliding window
beams (classic IMRT delivery) or as volumetrically modulated
arc therapy (VMAT). With the VMAT delivery, in addition to
the modulation of the radiation beam intensity, the gantry
speed and the dose rate can also vary during treatment. Such
complexity of treatment delivery requires accurate methods
to validate the dose prior to treatment delivery.
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The planning aspects of MLC-based IMRT represent a chal-
lenge, primarily because the IMRT beams consist of a large
number of control points (also known as segments) which
could, depending on their area, introduce conditions of elec-
tronic disequilibrium.23-24 For a complex intensity pattern, the
resulting dose distributions can be very sensitive to the de-
tailed structure of the MLC.23-25
The high definition multi-leaf collimator (HD-MLC) on the
NovalisTX Varian system has 60 leaf pairs (Varian Medical
System, Inc., Palo A lot, CA). The inner 32 leaf pairs have a
2.5 mm width projection at isocenter while the outer 28 leaf
pairs have a projection of 5 mm at isocenter. The purpose of
this study is to investigate the use of our previously presented
Monte Carlo model of the Novalis TX machine 23 for IMRT
and VMAT independent dose verification.
Methods and Materials
According to the American Association of Physicist in Medi-
cine (AAPM) task group report TG-105, Monte Carlo simu-
lations need to be performed under the same conditions as the
measurements. The authors have reported the Monte Carlo
modeling and benchmarking of a Novalis TX Varian 6 MV
with HD-120 multileaf collimator (MLC).23 The resulting
model of the Novalis TX linac from the precedent investiga-
tion was tested for regular and irregular fields defined by jaws
and by the MLC as well for leakage. A number of regular
fields ranging from 1×1 to 20×20 cm2 and irregular fields were
simulated and compared to the commissioning data from the
linac.23 The Monte Carlo model of the Novalis TX linac men-
tioned above was performed in two steps. First, a phase-space
file was obtained from the simulation of the treatment head at
a location immediately after the HD-MLC. The phase-space
files were then used as input for the dose calculations in the
phantom.
In the present investigation the Monte Carlo simulation of
dose deposition were implemented in two steps again. First, a
phase-space file was obtained from the simulation of the
treatment head at a location immediately after the Jaws for a
20×20 cm2 field using BEAMnrc code. Secondly, this
phase-space file was used as input for the dose calculation in
the phantom and patient CT using MCSIM code. The use in
this study of the MCSIM code was to speed up the computa-
tion time for the simulations by replacing the MLC by blocks
with the same characteristics of the MLC but with this feature
the entire simulation can be done in a single simulation and
calculate the dose for each control point for IMRT and VMAT
cases.
BEAMnrc simulations
Phase-space files for the different field size of the Novalis TX
6 MV photon beams were created using the
EGSnrc\BEAMnrc system.2, 5, 12 The cutoff energies used in
the simulations were ECUT = 700 keV for electrons and
PCUT = 10 keV for photons. A monoenergetic source of ki-
netic energy of the beam of 6 MeV was used with full width
at half maximum (FWHM) for the X and Y directions of 0.125
cm. Geometry and materials used to build the Monte Carlo
model of the linear accelerator were based on machine spec-
ifications as provided by the manufacturer. The linac was
structured in the following order: a target slab of tungsten and
copper, primary collimator of tungsten, flattening filter, ion
chamber, and jaws (tungsten), as in Figure 1. All materials
used in the MC simulation were extracted from the 700 ICRU
PEGS4 (preprocessor for Electron Gamma Shower) cross
section data available in BEAMnrc, and met the specifications
for the linac as provided by the manufacturer.23 Simulations
had a minimum requirement of 100,000 particles per cm2, this
was done to ensure reliable statistics in the phase-space file
generated by BEAMnrc simulations.
FIG. 1: Novalis TX linac head geometry in BEAMnrc.
Monte Carlo phantom for simulations
Using the stand-along code ct-create which is included in the
HEN-HOUSE/EGSnrc package of the BEAMnrc code CT data
sets can be converted to a phantom which relevant infor-
mation is written into the file (*.egsphant). This file contains
all the information needed in the MCSIM to perform the
simulations in this geometry which corresponds to the orig-
inal CT data from which it was extracted. Basically, ct-create
reads the original CT data (Pinnacle, CADPLAN, or DICOM
format), in our case DICOM format exported from the
treatment planning system (TPS). Then select a subvolume of
CT data, after that it resamples the CT resolution and finally it
convert the data to material and density. At the end a file is
written which contains the material and density data
(*.egsphant) which can be used in MCSIM (by changing the
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*.egsphant to *.egs4phant). In Figure 2, an example of how the
egs4phant created in ct-create can be visualized in the
mcshow software which is included in the MCSIM package.
For the present study a cylindrical phantom based on the
Tomotherapy (cheese) phantom (TomoTherapy, Inc., Madi-
son, WI) was created to calculate the dose and compare versus
TPS dose calculation. In order to contrast our results with
measurements a phantom of the Matrixx array (IBA Dosime-
try GmbH, Schwarzenbruck, Germany) was used to create a
phantom for this device and compare TPS, Monte Carlo sim-
ulations, and Matrixx measurements.
FIG. 2: Use of ct-create routine to convert CT data to *.egs4phant for Monte Carlo simulations.
FIG. 3: MCSIM simulation geometry and flow chart.
MCSIM simulations
Monte Carlo dose calculations were performed using the
phase space files described above (BEAMnrc) as source input.
The energy cutoffs in all simulations were ECUT = 700 keV
(rest mass + kinetic energy) for electrons and PCUT = 10 keV
for photons. First a Monte Carlo simulation for a 10×10 cm2
field defined with the 20×20 cm2 phase-space file as input in a
cube water phantom of dimensions 30×30×30 cm3 was con-
ducted, this simulation determined the defined dref (dose
reference) by which the simulation result is multiplied and
convert the results of the simulations to centigray (cGy). The
calibration of our model was defined using the cube phantom
described above with a source to surface distance (SSD) of 100
cm and obtained 1 cGy per monitor unit (MU) at dmax. The
error in the calibration simulation was less than 1% to the 10
maximum doses at the end of the simulation.
For the IMRT and VMAT simulations a cylindrical phantom
was used the so called cheese phantom with dimensions de-
scribed above. The Monte Carlo phantom of this geometry
(*.egs4phant) was created with the same CT data that was
used to create the TPS (Pinnacle) phantom. The simulations
parameters used were the same as before ECUT = 700 keV and
PCUT = 10 keV. The phase-space file for the 20×20 cm2 field
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from BEAMnrc simulations of the linac head was used as
input to the MCSIM simulation.
For each of the IMRT and VMAT plans the corresponding
Dicom-RT file was exported. In-house Matlab (Matlab 7.8.0
R2009a, The MathWorks Inc., Natick, Massachusetts) routine
was used to extract all the information needed to build a
script that later is used in MCSIM to simulate each case. The
matlab routine extract from the dicom-rt file the following
parameters in order to create the script file (*.egs4inp) used as
input in MCSIM: gantry angle, collimator angle, couch angle,
MU per control point, jaws position, and MLC position for
each control point. With the MLC position information a
block is built for each control point of each beam of the plan.
This block is saved as a text file and called later by the egs4inp
file during the simulation to act as the MLC geometry for the
control points. For the IMRT cases a block is built for each
control point of each beam of the original treatment. So each
beam has the same number of block as the number of control
points as it was defined by the TPS during optimization. For
the VMAT case each arc contains a number of control points
and the code create each control point as a corresponding
block. Figure 3 shows the flow chart of the MCSIM simula-
tion and the geometry of these simulations. For IMRT and
VMAT cases an error of less than 2% in the maximum 10
doses of the simulations was achieved.
Finally after the simulation MCSIM results are registered in a
matrix file dose (*.3ddose) which contains the dose in the
geometry used for the simulation. Again in-house matlab
code was used to convert this file to a Tomotherapy dose file
which can be read in the commercial RIT113 version 5.3
(Radiological Imaging Technology, Inc.) software to be
compared with TPS dose calculation and with Matrixx dose
measurements. As inhered to the final Tomotherapy dose file
is a 3D matrix the user once in RIT software need to select the
correct plane to be compared. For our simulations in the
cheese phantom a transverse central plane where the iso-
center was set was the plane used for comparison. For our
Matrixx comparison the coronal plane of the isocenter was
used for comparison since this is the plane where the ion
chamber array of the Matrixx device is located. An IMRT
plan was measured for this purpose with the Matrixx with all
beams delivered with the gantry at 180 degrees for simplicity.
Finally the dose measured with the Matrixx was exported as a
Dicom image to be compared to TPS and MCSIM dose cal-
culation in the RIT software.
Results
IMRT cases for different treatment sites were simulated and
compared against the dose calculated by the TPS. In this case
the simulations were performed over the cheese phantom
and the resulting dose from the simulation was converted to
a Tomotherapy dose matrix as explained before. In the RIT
software TPS and MCSIM simulation doses were compared
against each other and a dose difference of 3% and a distance
to agreement (DTA) of 3 mm were selected for the gamma
pass-fail criterion. Figure 4 shows the result for an IMRT
case with a resulting gamma analysis of 98.47% of the points
with a gamma less than 1 for the criterion mentioned. Pro-
files comparison shows an agreement within 3% dose dif-
ference in the comparison of TPS versus MCSIM results.
Deviation in the order of less than 3% of the calculated dose
is observed specially in the low dose region of the compari-
son. Similar results were observed for all IMRT cases simu-
lated.
FIG. 4: Comparison between TPS and MCSIM simulation for an IMRT delivery.
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FIG. 5: Comparison between TPS and MCSIM simulation for a VMAT delivery.
VMAT cases were simulated in the same cheese phantom geometry and the resulting dose calculations from MCSIM were con-
verted to a Tomotherapy dose matrix file and compared against TPS dose calculations in the RIT software. Figure 5 shows the
comparison for a VMAT case between TPS versus MCSIM simulation doses. For the gamma analysis a criterion of 3% dose dif-
ference and 3 mm DTA were used. The gamma result for this case was 98.53% of the points with a gamma index less than 1.
Small deviations of the dose were observed in the low dose region. Profiles comparisons have an agreement within 3% dose
difference.
TABLE 1: Gamma analysis results for IMRT and VMAT cases for TPS versus MCSIM simulations comparison in cheese phantom.
Modality Cases Gamma <1 (3%, 3 mm)
IMRT 10 (5 Pelvis, 3 brains, 2 HN) 97.5
VMAT 10 (5 Pelvis, 3 brains, 2 Lungs) 94.3
FIG. 6: IMRT result comparison between TPS and MCSIM simulation dose calculation (gamma 3%, 3 mm criterion) in Matrixx phantom geom-
etry.
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FIG. 7: IMRT result comparison between Matrixx measurements and MCSIM simulation dose calculation (gamma 3%, 3 mm criterion).
Table 1 show the gamma analysis results for 10 IMRT and 10
VMAT cases studied in the present investigation. And aver-
age of 97.1% passing gamma were obtained for the IMRT
cases and an average of 94.3% passing gamma for the VMAT
cases. Agreement within 3% of the dose between the profiles
was observed for the cases studied for IMRT and VMAT
modalities.
In order to benchmark the MCSIM dose simulations, these
were compared against actual measurements performed with
a Matrixx ion chamber array device for an IMRT case. Actual
measurements with the gantry angle at 180 degrees were
performed with the Matrixx phantom. A TPS dose calcula-
tion for this plan was exported. And finally a MCSIM simu-
lation over the Matrixx geometry was performed for the
same plan. The TPS dose calculation was compared first ver-
sus the MCSIM simulation dose results and comparison with
a gamma criterion (3%, 3 mm) was performed and illustrated
in Figure 6. The result shows that 99.83% of the points have
a gamma index less than 1. And Figure 7 shows the compar-
ison in RIT of the Matrixx measurements versus MCSIM
simulation for this IMRT case. A gamma criterion of 3%, 3
mm were used and the result shows 95.73% of the points
have a gamma index less than 1. Profiles comparison demon-
strates agreement within a 3% and deviations as high of 3%
in the low dose region but same differences were observed in
the TPS versus Matrixx comparison.
Conclusion
In the present work a Monte Carlo model of a Novalis TX
linac which has been tested and benchmarked to produce
phase-space files for the treatment head of the linac was used
to produce a input phase-space to calculated dose deposition
phenomena in different geometries for IMRT and VMAT
treatment modalities. The control points defined for the MLC
were replaced by blocks with the same characteristics and
materials of the linac MLC to speed up the simulation time.
With this technique a simulation of a typical IMRT case can
be performed with a 10 computer cluster in about 1.02 hours
in average. If the number of computer used is increased the
computing time can be reduced even more which make our
model suitable for clinical use as a second check method to
compare the TPS dose calculated.
Our results showed that for IMRT and VMAT deliveries with
a HD-MLC, there is an average of 95.9% of the points have a
gamma index less than 1 with our chosen criterion between
our Monte Carlo simulations and the corresponding meas-
urements and TPS calculations in a cylindrical water equiva-
lent phantom. This Monte Carlo code can be used as a
pre-treatment, independent dose calculation verification for
IMRT and VMAT deliveries.
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